Effect of Cilostazol on vascular endothelial function in type 2 diabetic patients with peripheral arterial disease
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes Peripheral arterial disease
- Registration Number
- JPRN-UMIN000003994
- Lead Sponsor
- The University of Tokyo Vascular Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active bleeding or bleedind tendency 2. Congestive heart failure 3. History of hypersensitivity to Cilostazol 4. Pregnancy 5. Severe hepatic or renal dysfunction 6. Uncontrolled proliferative retinopathy 7. Malignancy 8. Patients ineligible for the study determined by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Flow-mediated vasodilatation
- Secondary Outcome Measures
Name Time Method